最新ニュース Oragenics (AMEX:OGEN) 株価情報

Oragenics

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.

Oragenics Inc

<p>Wedbush  analyst Daniel Ives   reiterates Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) with a Outperform and maintains $300 price target.</p>


News

Price Target

Reiteration

Analyst Ratings

AAPL

Wedbush Reiterates Outperform on Apple, Maintains $300 Price Target

WIIM

APVO

Aptevo Therapeutics shares are trading lower after the company announced a 1-for-37 reverse stock split.

<p>Canaccord Genuity  analyst George Gianarikas   maintains Fluence Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) with a Buy and lowers the price target from $37 to $34.</p>


FLNC

Canaccord Genuity Maintains Buy on Fluence Energy, Lowers Price Target to $34

<p><strong>Tesla, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares are trading higher<a href="https://www.benzinga.com/movers" target="_blank" rel="noreferrer noopener"> Friday morning.</a></p>
<p>Tesla China shortened its payment cycle to supply chain partners to just 90 days in 2024, down from 100 days in 2023, according to <strong>Grace Tao</strong>, Tesla&#8217;s vice president of External Affairs, <a href="https://cnevpost.com/2024/11/28/tesla-china-payment-cycle-to-suppliers-90-days/" target="_blank" rel="noreferrer noopener">reported</a> CnEV Post.</p>
<p>Tao shared the update in a Weibo post, noting that four other unnamed new energy vehicle (NEV) makers still take over 150 days to settle payments.</p>
<p>This improvement is part of Tesla&#8217;s efforts to streamline operations and enhance supplier relationships.</p>
<p><strong>See Also:&nbsp;<a target="_blank" href="https://www.benzinga.com/24/11/42156817/tesla-rivian-settle-battery-tech-theft-dispute-after-nearly-4-years?itm_source=parsely-api" rel="noreferrer noopener">Tesla, Rivian Signal End To 4-Year Legal Battle Over Alleged Trade Secrets Theft</a></strong></p>
<p>Meanwhile, the EV behemoth revamped its referral program across North America as it races to a <a href="https://www.benzinga.com/news/24/10/41443856/tesla-offers-discounts-of-up-to-4k-on-select-model-3-y-vehicles-as-it-looks-to-avert-1st-ever-declin" target="_blank" rel="noreferrer noopener">delivery target of 515,000 vehicles</a> in the<a href="https://www.benzinga.com/markets/24/11/42207185/tesla-sweetens-referral-program-allowing-customers-to-earn-up-to-10000-as-elon-musks-ev-giant-races-to-500k-q4-delivery-target" target="_blank" rel="noreferrer noopener"> fourth quarter.</a> Tesla&#8217;s updated referral program includes enhanced discounts and rewards, with specific incentives for the Cybertruck.</p>
<p>The company recently started offering unlimited overnight charging via the&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/11/42081589/tesla-electric-offers-unlimited-overnight-charging-for-just-5-a-month-as-ev-giant-races-toward-5" rel="noreferrer noopener">Tesla Electric service</a>, down from $15 a month, aiming to attract more buyers.</p>
<p>This follows&nbsp;<a target="_blank" href="https://www.benzinga.com/news/24/10/41443856/tesla-offers-discounts-of-up-to-4k-on-select-model-3-y-vehicles-as-it-looks-to-avert-1st-ever-declin" rel="noreferrer noopener">discounts of up to $4,000</a> on select&nbsp;Model 3 and Model Y&nbsp;vehicles to avoid a decline in annual deliveries.</p>
<p>Despite these efforts,&nbsp;<a href="https://www.benzinga.com/tech/24/11/41894615/tesla-q4-deliveries-expected-to-set-new-records-but-not-enough-to-avoid-yearly-sales-decline-says-researcher" target="_blank" rel="noreferrer noopener">analysts predict</a> that Tesla's fourth-quarter deliveries will set new records but may not prevent a yearly sales decline. The&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41988194/trump-plans-to-erase-ev-tax-credit-analyst-says-its-net-bullish-calls-sell-off-wrong-knee-jerk-reaction" target="_blank" rel="noreferrer noopener">potential removal of the $7,500 EV tax credit</a>&nbsp;by the incoming Trump administration could further affect Tesla's sales, as highlighted by&nbsp;<a href="https://www.benzinga.com/news/global/24/11/41998381/tesla-earnings-will-be-hit-hardest-if-7500-ev-credit-is-cut-warns-gary-black-citing-80-dependence-on-ev-sales-please-do-the-math" target="_blank" rel="noreferrer noopener">Gary Black</a>, who warns of significant earnings impact if the credit is cut.</p>
<p><strong>TSLA</strong> <strong>Price Action</strong>: Tesla shares are trading higher by 2.51% to $341.18 at publication Friday.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/government/regulations/24/11/42160725/tesla-faces-environmental-violations-as-elon-musks-doge-prepares-for-garbage-collection-of-rules-that-dont-make-sense-report?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla Faces Environmental Violations As Elon Musk's ‘DOGE' Prepares For ‘Garbage Collection Of Rules That Don&#8217;t Make Sense</a></strong></li>
</ul>
<p><em>Photo: Courtesy Tesla</em></p>


Equities

Global

Markets

Movers

General

TSLA

Tesla China Shortens Payment Cycle To 90 Days In 2024: Report

<p>Financial giants have made a conspicuous bullish move on ASML Holding. Our analysis of options history for ASML Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) revealed 82 unusual trades.</p>
<p>Delving into the details, we found 57% of traders were bullish, while 36% showed bearish tendencies. Out of all the trades we spotted, 29 were puts, with a value of $2,588,601, and 53 were calls, valued at $4,795,957.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $580.0 to $800.0 for ASML Holding over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of ASML Holding stands at 313.4, with a total volume reaching 6,778.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in ASML Holding, situated within the strike price corridor from $580.0 to $800.0, throughout the last 30 days.</p>
<h3>ASML Holding 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732894317_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ASML</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$87.7</td>
<td>$86.9</td>
<td>$86.9</td>
<td>$760.00</td>
<td>$191.1K</td>
<td align="right">231</td>
<td align="right">22</td>
</tr>
<tr>
<td>ASML</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$86.8</td>
<td>$86.0</td>
<td>$86.0</td>
<td>$760.00</td>
<td>$189.2K</td>
<td align="right">231</td>
<td align="right">66</td>
</tr>
<tr>
<td>ASML</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$86.3</td>
<td>$85.5</td>
<td>$85.5</td>
<td>$750.00</td>
<td>$188.1K</td>
<td align="right">37</td>
<td align="right">66</td>
</tr>
<tr>
<td>ASML</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$41.2</td>
<td>$40.8</td>
<td>$41.2</td>
<td>$680.00</td>
<td>$168.9K</td>
<td align="right">334</td>
<td align="right">281</td>
</tr>
<tr>
<td>ASML</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$21.7</td>
<td>$20.9</td>
<td>$21.5</td>
<td>$690.00</td>
<td>$150.5K</td>
<td align="right">347</td>
<td align="right">75</td>
</tr>
</tbody>
</table>
</p>
<h3>About ASML Holding</h3>
<p>ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML's main clients are TSMC, Samsung, and Intel.</p>
<p>Following our analysis of the options activities associated with ASML Holding, we pivot to a closer look at the company's own performance.</p>
<h3>ASML Holding's Current Market Status</h3>
<ul>
<li>With a trading volume of 550,696, the price of ASML is up by 3.75%, reaching $695.64.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 61 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for ASML Holding</h3>
<p>Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $767.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Bernstein persists with their Outperform rating on ASML Holding, maintaining a target price of $767. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for ASML Holding, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

ASML

ASML Holding's Options Frenzy: What You Need to Know

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Tesla</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with TSLA, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 204 uncommon options trades for Tesla.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 47% bullish and 38%, bearish.</p>
<p>Out of all of the special options we uncovered, 54 are puts, for a total amount of $3,650,355, and 150 are calls, for a total amount of $11,585,823.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $5.0 to $700.0 for Tesla during the past quarter. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Tesla's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Tesla's whale trades within a strike price range from $5.0 to $700.0 in the last 30 days. </p>
<h3>Tesla Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732894311_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/06/24</td>
<td>$15.75</td>
<td>$15.3</td>
<td>$15.55</td>
<td>$330.00</td>
<td>$262.7K</td>
<td>3.4K</td>
<td>1.3K</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$3.05</td>
<td>$3.0</td>
<td>$3.05</td>
<td>$340.00</td>
<td>$171.3K</td>
<td>13.0K</td>
<td>65.1K</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>11/29/24</td>
<td>$5.9</td>
<td>$5.85</td>
<td>$5.85</td>
<td>$335.00</td>
<td>$152.1K</td>
<td>7.8K</td>
<td>13.2K</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$12.0</td>
<td>$11.7</td>
<td>$12.0</td>
<td>$330.00</td>
<td>$147.6K</td>
<td>10.8K</td>
<td>6.5K</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.65</td>
<td>$2.64</td>
<td>$2.64</td>
<td>$485.00</td>
<td>$131.2K</td>
<td>175</td>
<td>2.7K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Tesla</h3>
<p>Tesla is a vertically integrated battery electric vehicle automaker and developer of autonomous driving software. The company has multiple vehicles in its fleet, which include luxury and midsize sedans, crossover SUVs, a light truck, and a semi truck. Tesla also plans to begin selling more affordable vehicles, a sports car, and a robotaxi. Global deliveries in 2023 were a little over 1.8 million vehicles. The company sells batteries for stationary storage for residential and commercial properties including utilities and solar panels and solar roofs for energy generation. Tesla also owns a fast-charging network.</p>
<p>Having examined the options trading patterns of Tesla, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Current Position of Tesla</h3>
<ul>
<li>With a trading volume of 11,096,249, the price of TSLA is up by 1.86%, reaching $339.07.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 54 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Tesla</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $317.8.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Wedbush keeps a Outperform rating on Tesla with a target price of $400.<br />
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on Tesla with a target price of $350.<br />
&#x2A; An analyst from RBC Capital persists with their Outperform rating on Tesla, maintaining a target price of $313.<br />
&#x2A; An analyst from Jefferies persists with their Hold rating on Tesla, maintaining a target price of $300.<br />
&#x2A; An analyst from UBS persists with their Sell rating on Tesla, maintaining a target price of $226. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Tesla options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


What the Options Market Tells Us About Tesla

<p>Financial giants have made a conspicuous bullish move on Symbotic. Our analysis of options history for Symbotic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) revealed 8 unusual trades.</p>
<p>Delving into the details, we found 50% of traders were bullish, while 37% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $210,224, and 4 were calls, valued at $196,187.</p>
<h3>Expected Price Movements</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $22.0 to $37.5 for Symbotic over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Symbotic's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Symbotic's whale activity within a strike price range from $22.0 to $37.5 in the last 30 days. </p>
<h3>Symbotic Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732894306_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SYM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$0.95</td>
<td>$0.9</td>
<td>$0.95</td>
<td>$22.00</td>
<td>$101.3K</td>
<td>108</td>
<td>1.0K</td>
</tr>
<tr>
<td>SYM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$3.4</td>
<td>$3.1</td>
<td>$3.0</td>
<td>$25.00</td>
<td>$61.5K</td>
<td>1.3K</td>
<td>243</td>
</tr>
<tr>
<td>SYM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$7.6</td>
<td>$7.1</td>
<td>$7.25</td>
<td>$22.50</td>
<td>$53.6K</td>
<td>463</td>
<td>12</td>
</tr>
<tr>
<td>SYM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$1.75</td>
<td>$1.5</td>
<td>$1.5</td>
<td>$30.00</td>
<td>$45.0K</td>
<td>2.4K</td>
<td>294</td>
</tr>
<tr>
<td>SYM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$5.5</td>
<td>$5.3</td>
<td>$5.4</td>
<td>$27.50</td>
<td>$41.0K</td>
<td>365</td>
<td>115</td>
</tr>
</tbody>
</table>
</p>
<h3>About Symbotic</h3>
<p>Symbotic Inc is an automation technology company that develops technologies to improve operating efficiencies in modern warehouses. The group develops, commercializes, and deploys innovative, end-to-end technology solutions that dramatically improve supply chain operations. Symbotic also automates the processing of pallets and cases in large warehouses or distribution centers for some of the retail and wholesale companies in the world. The company operates in two geographical regions the United States and Canada. Key revenue is generated from the United States.</p>
<p>Having examined the options trading patterns of Symbotic, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Current Position of Symbotic</h3>
<ul>
<li>With a trading volume of 3,288,012, the price of SYM is up by 6.44%, reaching $25.54.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 66 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Symbotic</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $43.4.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from Needham continues to hold a Buy rating for Symbotic, targeting a price of $46.<br />
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $60.<br />
&#x2A; Consistent in their evaluation, an analyst from BWS Financial keeps a Sell rating on Symbotic with a target price of $10.<br />
&#x2A; Consistent in their evaluation, an analyst from Northland Capital Markets keeps a Outperform rating on Symbotic with a target price of $53.<br />
&#x2A; Consistent in their evaluation, an analyst from Keybanc keeps a Overweight rating on Symbotic with a target price of $48. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Symbotic, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Symbotic Unusual Options Activity

<p>Wedbush  analyst Yun Zhong   assumes Passage Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PASG#NASDAQ">PASG</a>) with a Outperform rating and announces Price Target of $4.</p>


Initiation

PASG

Wedbush Assumes Passage Bio at Outperform, Announces Price Target of $4

BGM Group shares are trading higher after the company announced its acquisition of the intelligent platform of AIX Inc., valued at approximately $140 million.

<p>Developmental-stage biopharmaceutical company <strong>Silo Pharma, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILO#NASDAQ">SILO</a>) shares are<a href="https://www.benzinga.com/movers" target="_blank" rel="noreferrer noopener"> trading higher on Friday</a>.</p>
<p>The company has announced a collaboration with Kymanox to develop a specialized subcutaneous insertion device for SP-26, its ketamine-loaded implant aimed at treating <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g42243217/silo-pharma-enters-joint-development-agreement-for-sp-26-ketamine-implant-device-targeting-pain-ma" rel="noreferrer noopener">fibromyalgia and chronic pain</a>.</p>
<p>The agreement includes a proof-of-concept design phase followed by prototype testing to determine the optimal tissue insertion depth.</p>
<p>Silo Pharma&#8217;s CEO, Eric Weisblum, highlighted that previous trials have confirmed the implant&#8217;s optimal formulation, and the focus now shifts to refining the insertion device for preclinical studies.</p>
<p>&#8220;Now we are advancing this program to develop a novel insertion device that is intended to be tested in continuing preclinical studies,&#8221; Weisblum added.</p>
<p><strong>Also Read: <a target="_blank" href="https://www.benzinga.com/24/11/42244387/nvidia-lam-reasearch-applied-materials-stocks-gain-as-biden-government-eyes-softer-semiconductor-sanctions-against-china" rel="noreferrer noopener">Nvidia, Chip Stocks Gain On Reports Of Softer China Sanctions</a></strong></p>
<p>If clinically successful, SP-26 could qualify for the FDA&#8217;s streamlined 505(b)(2) regulatory pathway for drug approval, the company said.</p>
<p>SP-26 is designed with the goal of meeting FDA safety standards for at-home use. In addition to the SP-26 project, Kymanox also serves as Silo&#8217;s regulatory partner for SPC-15, a treatment for stress-related disorders like PTSD.</p>
<p>According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, SILO stock has lost over 39% in the past year.</p>
<p><strong>Price Action:</strong> SILO shares are trading higher by 6.68% to $0.9601 at last check Friday.</p>
<p><strong>Also Read:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/news/global/24/11/42198109/nvidia-blackwell-supplier-vishay-intertechnology-likey-to-see-upside-courtesy-of-ai-frenzy-analyst" target="_blank" rel="noreferrer noopener">Nvidia Blackwell Supplier Vishay Intertechnology Likely To See Upside Courtesy Of AI Frenzy: Analyst</a></strong></li>
</ul>
<p><em>Photo via Shutterstock.</em></p>


SILO

Why Is Silo Pharma Stock Gaining Today?

<p>RBC Capital  analyst Paul Treiber   maintains Descartes Systems Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSGX#NASDAQ">DSGX</a>) with a Outperform and raises the price target from $115 to $133.</p>


DSGX

RBC Capital Maintains Outperform on Descartes Systems Gr, Raises Price Target to $133

Trading Ideas

AIEV

Thunder Power Holdings Shares Halted On Circuit Breaker To Upside

<p>RBC Capital  analyst Brian Abrahams   downgrades Applied Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLT#NASDAQ">APLT</a>) from Outperform to Sector Perform and lowers the price target from $12 to $4.</p>


Downgrades

APLT

RBC Capital Downgrades Applied Therapeutics to Sector Perform, Lowers Price Target to $4

<p><strong>Yum China Holdings, Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>) shares are trading slightly lower in the morning session on Friday.</p>
<p>The company is making significant strides in modernizing its supply chain with the official launch of its <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n42237680/yum-china-officially-launches-digital-supplier-recruitment-platform-at-china-international-supply-" rel="noreferrer noopener">digital supplier recruitment platform</a>.</p>
<p>Unveiled at the 2nd China International Supply Chain Expo, the platform invites high-quality enterprises globally to join the company&#8217;s expansive supply chain network.</p>
<p>This platform marks a shift from traditional supplier selection to a data-driven and interactive process. By enabling potential suppliers to submit their credentials online, Yum China simplifies the engagement process, significantly reducing the time and manual effort required for supplier evaluation.</p>
<p>It also promotes transparency and fairness in selection, aligning with the company&#8217;s &#8220;Spend Better, Buy Better&#8221; initiative aimed at enhancing operational efficiency.</p>
<p>Since its pilot launch in April 2024, the platform has already attracted applications across more than 30 categories, covering over a third of the company&#8217;s total categories.</p>
<p><strong>Also Read: <a target="_blank" href="https://www.benzinga.com/24/11/42241785/us-futures-signal-gains-on-the-truncated-trading-day-will-december-witness-a-santa-claus-rally-analysts-decode" rel="noreferrer noopener">US Stocks Likely To Open In The Green To End November On A High: Are Markets Set For A Santa Claus Rally In December? Analysts Decode</a></strong></p>
<p>At the launch ceremony, Yum China also signed agreements with both domestic and international companies, focusing on sourcing and product innovation to improve the culinary experience for its customers.</p>
<p>Yum China&#8217;s supply chain management system already includes over 800 core suppliers across diverse categories, such as food ingredients, beverages, and packaging materials. Leveraging this vast network, the company delivers safe and diverse menu options tailored to the tastes of Chinese consumers.</p>
<p>For FY24, Yum China plans to open 1,500 to 1,700 new stores, invest $700 million to $850 million in capital expenditures, and return $1.5 billion to shareholders <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/41709548/yum-china-q3-earnings-surprise-kfc-pizza-hut-power-earnings-beat-reiterates-capex-plan-to-open-1-50" rel="noreferrer noopener">through dividends and share repurchases</a>.</p>
<p><strong>Price Action: </strong>YUMC shares are trading lower by 0.73% to $46.44 at last check Friday.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="http://gop%20megadonor%20ken%20griffin%20slashes%20citadel's%20palantir%20stake%20by%2091%25,%20bets%20big%20on%20nvidia%20as%20jensen%20huang-led%20company%20rises%20over%20180%25%20in%202024/" target="_blank" rel="noreferrer noopener">GOP Megadonor Ken Griffin Slashes Citadel&#8217;s Palantir Stake By 91%, Bets Big On Nvidia As Jensen Huang-Led Company Rises Over 180% In 2024</a></strong></li>
</ul>
<p><em>Photo by aleks-dorohovich- for Unsplash.</em></p>


YUMC

Yum China Unveils New Platform For Supplier Recruitment With Speed And Transparency

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Bank of America</strong>.</p>
<p>Looking at options history for Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) we detected 9 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 55% of the investors opened trades with bullish expectations and 44% with bearish.</p>
<p>From the overall spotted trades, 7 are puts, for a total amount of $351,268 and 2, calls, for a total amount of $128,420.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $32.0 to $60.0 for Bank of America over the recent three months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Bank of America stands at 5699.0, with a total volume reaching 4,464.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Bank of America, situated within the strike price corridor from $32.0 to $60.0, throughout the last 30 days.</p>
<h3>Bank of America Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732893380_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$0.62</td>
<td>$0.6</td>
<td>$0.6</td>
<td>$45.00</td>
<td>$90.0K</td>
<td>3.8K</td>
<td>1.5K</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$16.0</td>
<td>$15.85</td>
<td>$16.0</td>
<td>$32.00</td>
<td>$80.0K</td>
<td>21.1K</td>
<td>50</td>
</tr>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.21</td>
<td>$2.17</td>
<td>$2.2</td>
<td>$49.00</td>
<td>$50.6K</td>
<td>1.1K</td>
<td>679</td>
</tr>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$2.6</td>
<td>$2.53</td>
<td>$2.6</td>
<td>$49.00</td>
<td>$50.1K</td>
<td>305</td>
<td>194</td>
</tr>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.23</td>
<td>$2.18</td>
<td>$2.22</td>
<td>$49.00</td>
<td>$50.1K</td>
<td>1.1K</td>
<td>225</td>
</tr>
</tbody>
</table>
</p>
<h3>About Bank of America</h3>
<p>Bank of America is one of the largest financial institutions in the United States, with more than $3.0 trillion in assets. It is organized into four major segments: consumer banking, global wealth and investment management, global banking, and global markets. Bank of America's consumer-facing lines of business include its network of branches and deposit-gathering operations, retail lending products, credit and debit cards, and small-business services. The company's Merrill Lynch operations provide brokerage and wealth-management services, as does its private bank. Wholesale lines of business include investment banking, corporate and commercial real estate lending, and capital markets operations. Bank of America has operations in several countries but is primarily US-focused.</p>
<p>Having examined the options trading patterns of Bank of America, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is Bank of America Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 3,021,732, the BAC's price is down by -0.01%, now at $47.77. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 48 days.</li>
</ul>
<h3>Professional Analyst Ratings for Bank of America</h3>
<p>In the last month, 3 experts released ratings on this stock with an average target price of $55.333333333333336.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; In a positive move, an analyst from Citigroup has upgraded their rating to Buy and adjusted the price target to $54.<br />
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Bank of America, which currently sits at a price target of $56.<br />
&#x2A; Consistent in their evaluation, an analyst from Oppenheimer keeps a Outperform rating on Bank of America with a target price of $56. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Bank of America with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Bank of America's Options Frenzy: What You Need to Know

<p>Financial giants have made a conspicuous bearish move on Novo Nordisk. Our analysis of options history for Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) revealed 14 unusual trades.</p>
<p>Delving into the details, we found 35% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $210,005, and 9 were calls, valued at $379,290.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $105.0 to $111.0 for Novo Nordisk over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Novo Nordisk's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Novo Nordisk's significant trades, within a strike price range of $105.0 to $111.0, over the past month.</p>
<h3>Novo Nordisk 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732893375_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/13/24</td>
<td>$5.6</td>
<td>$5.05</td>
<td>$5.29</td>
<td>$105.00</td>
<td>$159.0K</td>
<td>171</td>
<td align="right">300</td>
</tr>
<tr>
<td>NVO</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$8.35</td>
<td>$8.0</td>
<td>$8.2</td>
<td>$110.00</td>
<td>$42.6K</td>
<td>7.0K</td>
<td align="right">273</td>
</tr>
<tr>
<td>NVO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$8.2</td>
<td>$8.1</td>
<td>$8.1</td>
<td>$110.00</td>
<td>$42.1K</td>
<td>7.0K</td>
<td align="right">116</td>
</tr>
<tr>
<td>NVO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$8.2</td>
<td>$8.1</td>
<td>$8.1</td>
<td>$110.00</td>
<td>$42.1K</td>
<td>7.0K</td>
<td align="right">64</td>
</tr>
<tr>
<td>NVO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$7.7</td>
<td>$7.5</td>
<td>$7.5</td>
<td>$109.00</td>
<td>$42.0K</td>
<td>351</td>
<td align="right">56</td>
</tr>
</tbody>
</table>
</p>
<h3>About Novo Nordisk</h3>
<p>With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.</p>
<h3>Where Is Novo Nordisk Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 358,592, with NVO's price down by -0.65%, positioned at $105.44.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 61 days.</li>
</ul>
<h3>Expert Opinions on Novo Nordisk</h3>
<p>1 market experts have recently issued ratings for this stock, with a consensus target price of $160.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $160. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Novo Nordisk, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


What the Options Market Tells Us About Novo Nordisk

<p>Deep-pocketed investors have adopted a bullish approach towards Walt Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DIS usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Walt Disney. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 50% leaning bullish and 12% bearish. Among these notable options, 2 are puts, totaling $139,292, and 6 are calls, amounting to $336,113.</p>
<h3>What's The Price Target?</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $75.0 to $120.0 for Walt Disney during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Walt Disney's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Walt Disney's whale trades within a strike price range from $75.0 to $120.0 in the last 30 days. </p>
<h3>Walt Disney Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732893369_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$46.0</td>
<td>$44.8</td>
<td>$46.0</td>
<td>$75.00</td>
<td>$115.0K</td>
<td>376</td>
<td align="right">25</td>
</tr>
<tr>
<td>DIS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$2.3</td>
<td>$2.27</td>
<td>$2.27</td>
<td>$115.00</td>
<td>$112.5K</td>
<td>3.4K</td>
<td align="right">522</td>
</tr>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$8.0</td>
<td>$7.85</td>
<td>$8.0</td>
<td>$115.00</td>
<td>$85.6K</td>
<td>3.6K</td>
<td align="right">8</td>
</tr>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$4.6</td>
<td>$4.5</td>
<td>$4.55</td>
<td>$120.00</td>
<td>$51.8K</td>
<td>3.5K</td>
<td align="right">136</td>
</tr>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$1.82</td>
<td>$1.77</td>
<td>$1.82</td>
<td>$116.00</td>
<td>$29.4K</td>
<td>1.7K</td>
<td align="right">207</td>
</tr>
</tbody>
</table>
</p>
<h3>About Walt Disney</h3>
<p>Disney operates in three global business segments: entertainment, sports, and experiences. Entertainment and experiences both benefit from the firm's ownership of iconic franchises and characters. Entertainment includes the ABC broadcast network, several cable television networks, and the Disney+ and Hulu streaming services. Within the segment, Disney also engages in movie and television production and distribution, with content licensed to movie theaters, other content providers, or, increasingly, kept in-house for use on Disney's own streaming platform and television networks. The sports segment houses ESPN and the ESPN+ streaming service. Experiences contains Disney's theme parks and vacation destinations, and also benefits from merchandise licensing.</p>
<p>In light of the recent options history for Walt Disney, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Where Is Walt Disney Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 909,998, the DIS's price is down by -0.55%, now at $116.95. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 68 days.</li>
</ul>
<h3>What Analysts Are Saying About Walt Disney</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $127.2.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Evercore ISI Group persists with their Outperform rating on Walt Disney, maintaining a target price of $128.<br />
&#x2A; An analyst from Bernstein has decided to maintain their Outperform rating on Walt Disney, which currently sits at a price target of $120.<br />
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Overweight rating on Walt Disney with a target price of $125.<br />
&#x2A; Consistent in their evaluation, an analyst from Loop Capital keeps a Buy rating on Walt Disney with a target price of $125.<br />
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Walt Disney, which currently sits at a price target of $138. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Walt Disney with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Decoding Walt Disney's Options Activity: What's the Big Picture?

<p><strong>DevvStream Corp.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DEVS#NASDAQ">DEVS</a>) announced an agreement to <a target="_blank" href="https://www.newsfilecorp.com/release/231880" rel="noreferrer noopener">acquire </a>all renewable and carbon assets from the Medellin Solar Power Facility in the form of international renewable energy certificates (I-RECs).</p>
<p>The Medellin Solar Power Facility, with a 730 MWp capacity, is part of the &#8220;2030 Smart City&#8221; plan in Cebu, Philippines. Developed by Sogod Energy Inc., it will generate 1.2 million I-RECs annually from 1.219 million MWh of energy.</p>
<p>I-RECs certify 1 MWh of renewable energy generated and injected into the grid. Organizations buy them to meet renewable energy goals, support clean energy, and report sustainability while ensuring credibility through the globally recognized I-REC Standard.</p>
<p>The agreement grants DevvStream full ownership of renewable energy and carbon assets, marking its entry into global energy transition markets. This milestone also advances the &#8220;Project Development&#8221; tier of the Company&#8217;s corporate strategy, reinforcing its role in sustainability.</p>
<p>The development of the Medellin Solar Power facility will proceed in three phases. Phase 1 is expected to be completed within 6 months, and the first I-RECs are anticipated to be produced approximately one month after its completion.</p>
<p>&#8220;While our roots are in carbon, DevvStream maintains a diverse asset portfolio, representing a range of environmental and energy transition assets,&#8221; said Sunny Trinh, CEO of DevvStream.</p>
<p>&#8220;I-RECs present a new opportunity for diversification and growth, particularly in the Asian segment, which accounts for approximately 70% of the world&#8217;s total installed solar capacity. To penetrate this market, we are starting with ASEAN member states, where demand is strong and prices are correspondingly higher. The rise of the I-REC market in Asia overall has been significant in recent years, offering DevvStream a strong path toward revenue while broadening the Company&#8217;s environmental impact and global reach.&#8221;</p>
<p><strong>Price Action:</strong> DEVS shares are trading higher by 30.6% at $1.00 last check Friday.</p>
<p><em>Image via Shutterstock</em></p>


DEVS

DevvStream Taps Asia's Soaring I-REC Market with Medellin Solar Deal; Stock Jumps

<p><strong>Bolt Projects Holdings, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSLK#NASDAQ">BSLK</a>) shares are moving higher on Friday. The company announced a private placement of 1.06 million shares at 34 cents per share. Here&#8217;s what you <a href="https://www.benzinga.com//node/42242876">need to know</a>.</p>
<p><strong>What To Know: </strong>A filing with the Securities and Exchange Commission reveals that the private placement raised $360,000 in funding and involved participation from several company executives.</p>
<p>The group of investors includes CEO <strong>Daniel Widmaier</strong>, Interim CFO <strong>Randy Beufumo</strong>, and Chief Technology Officer <strong>David Breslauer</strong>.</p>
<p>Bolt Projects is experiencing unusually high trading activity with 49 million shares exchanged in the current session, far exceeding its 100-day average session volume of 833.95 thousand shares.</p>
<p><strong>How To Buy Bolt Projects Shares </strong></p>
<p>By now you're likely curious about how to participate in the market for Bolt Projects Holdings &#8211; be it to purchase shares, or even attempt to bet against the company.</p>
<p>Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.</p>
<p>In the case of Bolt Projects Holdings, which is trading at $0.86 as of publishing time, $100 would buy you 116.28 shares of stock.</p>
<p>If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.</p>
<p><strong>See Also: <a href="https://www.benzinga.com/real-estate/24/11/42244420/more-freedom-why-joe-rogan-left-l-a-for-a-14-4-million-mansion-on-lake-austin">&#8216;More Freedom&#8217;: Why Joe Rogan Left L.A. For A $14.4 Million Mansion On Lake Austin</a></strong></p>
<p><strong>BSLK Price Action:</strong> At the time of publication, Bolt shares are trading 237.7% higher at 99 cents, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>
<p><em>Image: Image via Pexels</em></p>


BSLK

What's Going On With Bolt Projects Shares Friday?

SOS Ltd. shares are trading higher after the company recently announced that its board of directors approved a $50 million investment to purchase Bitcoin.

Oragenics prices public offering of common stock

Oragenics unveils automated intranasal device for treating concussed patients

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Oragenics</strong> (NYSEMKT:<span><a href="https://investorplace.com/stock-quotes/ogen-stock-quote/"><strong>OGEN</strong></a></span>) just reported results for the fourth quarter of 2023.</p><ul><li>Oragenics reported earnings per share of -$5.48.</li><li>The company did not report any revenue for the quarter.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/06/ogen-stock-earnings-oragenics-for-q4-of-2023/">OGEN Stock Earnings: Oragenics Reported Results for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

OGEN Stock Earnings: Oragenics Reported Results for Q4 2023

Earnings Week Ahead: Walmart, Home Depot, Alibaba, Cisco and more

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Oragenics</strong> (NYSEMKT:<span><a href="https://investorplace.com/stock-quotes/ogen-stock-quote/"><strong>OGEN</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>Oragenics reported earnings per share of -51 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/08/ogen-stock-earnings-oragenics-for-q2-of-2024/">OGEN Stock Earnings: Oragenics Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

OGEN Stock Earnings: Oragenics Reported Results for Q2 2024

Oragenics files to sell 2.4M shares of common stock

Oragenics stock plummets on selling 8.1M shares at $0.55 in public offering

An update from Oragenics ( ($OGEN) ) is now available. On September 19, 2024, the Compensation Committee and Board of Directors of a company awarde...

Oragenics Executive Compensation and Shareholder Meeting Updates

Oragenics ( ($OGEN) ) just unveiled an update. Oragenics, Inc. is poised to engage potential investors and industry analysts with its latest presen...

Oragenics Shares Investor Presentation Online

Earnings week ahead: NVDA, WMT, SNOW, TGT, BIDU, NIO, ZIM, and more

ABEO

AMAT

ASTS

ASXC

ATOS

AVXL

AYRO

BABA

BATL

BEEM

BEKE

BIDU

BLDP

BLUE

BTBT

BZUN

CARA

CATX

CMCM

COCP

CPRT

CRNC

CSCO

CTRM

EBON

ESLT

ESPR

ESTC

FUTU

GALT

GASS

GLNG

GOEV

GOLD

GRAB

HUYA

IMMR

INTU

JAGX

KEYS

KNDI

LITE

MBOT

MDAI

MIRA

MMAT

MNDY

NEGG

NNDM

NNOX

NTAP

NVDA

OCSL

OGEN

OUST

PANW

PSFE

ROST

RRAC

SACH

SBLK

SNOW

STNE

TAYD

TCEHY

TCOM

TCRT

TWST

UAVS

VIPS

VUZI

WKHS

XPEV

XXII

Health Care

Press Releases

Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study

Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature Range

"Explosive Growth Stocks: Innovations, Strategy, Earners Unlock Prime Potential CXAI, OGEN, PRSO, INBS, KAVL"

Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYSE American Continued Listing Standards

Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients

Oragenics, Inc. Announces Pricing of Public Offering

Financing

Oragenics, Inc. Announces Closing of Public Offering

Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002

Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation

Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit

Comments

Oragenics

ニュース

最新ニュース Oragenics (AMEX:OGEN) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル